Reuters | May 2, 2023
By Bhanvi Satija and Raghav Mahobe (Reuters) – Pfizer Inc on Tuesday reported higher-than-expected first-quarter revenue and profit, buoyed by demand for its COVID-19 products, and reaffirmed its 2023 earnings forecast as it banks on newer drugs to contribute to growth later this year. The company has said it expects 2023 to be a low […]
Reuters | April 26, 2023
By Khushi Mandowara and Leroy Leo (Reuters) -Humana Inc raised its annual adjusted profit forecast on Wednesday after lower medical costs in the firm’s government-backed health insurance business helped it beat profit estimates for the first quarter. The company’s upbeat outlook contrasts the uncertainty around 2024 earnings for health insurers staring at the end of […]
Reuters | April 11, 2023
By Jody Godoy and Bharat Gautam (Reuters) – A U.S. judge on Monday denied Theranos founder Elizabeth Holmes’ request to remain free on bail while she appeals her conviction on charges of defrauding investors in the failed blood-testing startup that was once valued at $9 billion. Holmes, who rose to fame after claiming Theranos’ small […]
Reuters | March 27, 2023
By Brendan Pierson (Reuters) – E-cigarette company Juul Labs Inc and its former largest investor, Marlboro maker Altria Group Inc, will face their first U.S. trial this week over claims that they created a public nuisance by marketing addictive e-cigarettes to minors. Minnesota seeks to force the companies to pay for measures to remedy the […]
Reuters | March 13, 2023
By Manas Mishra and Michael Erman (Reuters) -Pfizer Inc on Monday struck a $43 billion deal to acquire Seagen Inc and its targeted cancer therapies as it braces for a steep fall in COVID-19 sales and generic competition for some top-selling drugs. Seagen marks Pfizer’s largest purchase in a string of recent acquisitions utilizing a […]
Always be feeding your money brain. Claim one or all of the FREE offers from some of our partners below.